LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Biomedical Structures Expands, Adds VP
Company News

Biomedical Structures Expands, Adds VP

January 10, 2013 2 min read Premium comments

Advertisement

Biomedical Structures Expands, Adds VP
Source: Wikimedia Commons and KoS
Secondary

Biomedical Structures LLC (BMS) has announced the expansion of its facilities for medical textile development and manufacturing. The expansion includes a 10, 000 sq.-foot addition, which will support the engineering center for new product development, and a significant increase in total cleanrooms for biomedical textile development. BMS has complemented this expanded capacity with the appointment of medical device industry veteran Jonathan Howe to vice president of research and development.

" data-large-file="https://i0.wp.com/ryortho.com/wp-content/uploads/2013/01/JonathanHowe_WEB.jpg?fit=220%2C295&ssl=1" title="Jonathan Howe" src="https://i0.wp.com/ryortho.com/wp-content/uploads/2013/01/JonathanHowe_WEB.jpg?resize=220%2C295&ssl=1" alt="" width="220" height="295">
Jonathan Howe

New ultrasonic and roll-to-roll triple cleaning capabilities are part of the expanded cleanroom space, which triples BMS’ 2011 total. BMS has also increased weaving capacity with advanced equipment to accommodate demand for vascular grafts, synthetic tendons and orthopedic tissue repair, and other woven textile structures. Howe will bring more than 15 years of experience developing solutions for the spine, sports medicine, and interventional cardiovascular markets to help BMS meet the precise performance requirements of these device textiles.

Prior to joining BMS, Howe was the former director of research and development at DePuy Spine, where he activated, developed and led a global product portfolio designed to grow DePuy Spine’s market share, including the invention of lumbar spine and cervical interbody devices. He has also served as the director of new product development for DePuy Mitek, a soft tissue repair/sports medicine device company, and as a product development engineer at Cordis, where he specialized in cardiovascular and neurovascular implants. Howe holds numerous patents and has launched dozens of products and product development programs. He received his BS in Biomedical Engineering from Rensselaer Polytechnic Institute and his MS in Mechanical Engineering and MBA from Massachusetts Institute of Technology.

“BMS is thrilled to welcome Jonathan Howe to our R&D team, ” said BMS CEO Dean Tulumaris, in the January 8, 2013 news release. “We are experiencing a tremendous demand for our biomedical textiles for increasingly sophisticated solutions across the orthopedic and cardiovascular markets. Jonathan’s track record of device development and innovative engineering approach are a great fit for our customers’ needs as they continue to evolve.”

“Biomedical textiles can provide the perfect solution for many medical device engineering challenges, ” said Howe. “A cutting-edge medical textile developer like BMS is in the middle of a perfect storm of opportunity as device engineers look to improve performance and move toward more lifelike solutions for patients. I’m excited to join the BMS team with the chance to truly innovate on established designs.”

Asked about the spine and sports medicine applications they are working on, Tulumaris told OTW, “We are working with our orthopedic partners developing fixation devices for spinal applications and other novel surgical assist fabrics for our sports medicine clients. Med device engineers are turning to Biomedical Structures for our fabric solutions as these materials offer highly functional and resilient properties.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy